149 related articles for article (PubMed ID: 22120277)
21. Platelet-derived growth factor receptor-beta is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas.
Plate KH; Breier G; Farrell CL; Risau W
Lab Invest; 1992 Oct; 67(4):529-34. PubMed ID: 1434531
[TBL] [Abstract][Full Text] [Related]
22. Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival.
Bian XW; Yang SX; Chen JH; Ping YF; Zhou XD; Wang QL; Jiang XF; Gong W; Xiao HL; Du LL; Chen ZQ; Zhao W; Shi JQ; Wang JM
Neurosurgery; 2007 Sep; 61(3):570-8; discussion 578-9. PubMed ID: 17881971
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1.
Hsu SC; Volpert OV; Steck PA; Mikkelsen T; Polverini PJ; Rao S; Chou P; Bouck NP
Cancer Res; 1996 Dec; 56(24):5684-91. PubMed ID: 8971176
[TBL] [Abstract][Full Text] [Related]
24. A rat glioblastoma model with diffuse leptomeningeal gliomatosis induced by intracarotid injection of C6 glioma cells.
Wasita B; Kamitani H; Kinoshita Y; Mamun MH; Watanabe T
Neurol Res; 2009 Jun; 31(5):453-62. PubMed ID: 19309540
[TBL] [Abstract][Full Text] [Related]
25. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development.
Hong YK; Chung DS; Joe YA; Yang YJ; Kim KM; Park YS; Yung WK; Kang JK
Clin Cancer Res; 2000 Aug; 6(8):3354-60. PubMed ID: 10955823
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of glioblastoma growth in a highly invasive nude mouse model can be achieved by targeting epidermal growth factor receptor but not vascular endothelial growth factor receptor-2.
Martens T; Laabs Y; Günther HS; Kemming D; Zhu Z; Witte L; Hagel C; Westphal M; Lamszus K
Clin Cancer Res; 2008 Sep; 14(17):5447-58. PubMed ID: 18765536
[TBL] [Abstract][Full Text] [Related]
27. Biochanin A inhibits endothelial cell functions and proangiogenic pathways: implications in glioma therapy.
Jain A; Lai JC; Bhushan A
Anticancer Drugs; 2015 Mar; 26(3):323-30. PubMed ID: 25501542
[TBL] [Abstract][Full Text] [Related]
28. Antiangiogenic gene therapy in a rat glioma model using a dominant-negative vascular endothelial growth factor receptor 2.
Machein MR; Risau W; Plate KH
Hum Gene Ther; 1999 May; 10(7):1117-28. PubMed ID: 10340544
[TBL] [Abstract][Full Text] [Related]
29. Decreased expression of heparanase in glioblastoma multiforme.
Ueno Y; Yamamoto M; Vlodavsky I; Pecker I; Ohshima K; Fukushima T
J Neurosurg; 2005 Mar; 102(3):513-21. PubMed ID: 15796387
[TBL] [Abstract][Full Text] [Related]
30. Tissue factor, osteopontin, alphavbeta3 integrin expression in microvasculature of gliomas associated with vascular endothelial growth factor expression.
Takano S; Tsuboi K; Tomono Y; Mitsui Y; Nose T
Br J Cancer; 2000 Jun; 82(12):1967-73. PubMed ID: 10864205
[TBL] [Abstract][Full Text] [Related]
31. Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy.
Lucio-Eterovic AK; Piao Y; de Groot JF
Clin Cancer Res; 2009 Jul; 15(14):4589-99. PubMed ID: 19567589
[TBL] [Abstract][Full Text] [Related]
32. Downregulating FPR restrains xenograft tumors by impairing the angiogenic potential and invasive capability of malignant glioma cells.
Chen DL; Ping YF; Yu SC; Chen JH; Yao XH; Jiang XF; Zhang HR; Wang QL; Bian XW
Biochem Biophys Res Commun; 2009 Apr; 381(3):448-52. PubMed ID: 19233142
[TBL] [Abstract][Full Text] [Related]
33. Angiogenesis and invasion in glioma.
Onishi M; Ichikawa T; Kurozumi K; Date I
Brain Tumor Pathol; 2011 Feb; 28(1):13-24. PubMed ID: 21221826
[TBL] [Abstract][Full Text] [Related]
34. Evidence for telomerase involvement in the angiogenesis of astrocytic tumors: expression of human telomerase reverse transcriptase messenger RNA by vascular endothelial cells.
Pallini R; Pierconti F; Falchetti ML; D'Arcangelo D; Fernandez E; Maira G; D'Ambrosio E; Larocca LM
J Neurosurg; 2001 Jun; 94(6):961-71. PubMed ID: 11409526
[TBL] [Abstract][Full Text] [Related]
35. Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion.
Grobben B; De Deyn PP; Slegers H
Cell Tissue Res; 2002 Dec; 310(3):257-70. PubMed ID: 12457224
[TBL] [Abstract][Full Text] [Related]
36. Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas.
Lun X; Senger DL; Alain T; Oprea A; Parato K; Stojdl D; Lichty B; Power A; Johnston RN; Hamilton M; Parney I; Bell JC; Forsyth PA
J Natl Cancer Inst; 2006 Nov; 98(21):1546-57. PubMed ID: 17077357
[TBL] [Abstract][Full Text] [Related]
37. Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis.
Koga K; Todaka T; Morioka M; Hamada J; Kai Y; Yano S; Okamura A; Takakura N; Suda T; Ushio Y
Cancer Res; 2001 Aug; 61(16):6248-54. PubMed ID: 11507079
[TBL] [Abstract][Full Text] [Related]
38. Thrombin up-regulates vascular endothelial growth factor in experimental gliomas.
Xu Y; Gu Y; Keep RF; Heth J; Muraszko KM; Xi G; Hua Y
Neurol Res; 2009 Sep; 31(7):759-65. PubMed ID: 19108760
[TBL] [Abstract][Full Text] [Related]
39. Antitumor effect of endostatin overexpressed in C6 glioma cells is associated with the down-regulation of VEGF.
Yang L; Lin Z; Lin J; Weng S; Huang Q; Zhang P; Fu J
Int J Oncol; 2011 Feb; 38(2):465-71. PubMed ID: 21165557
[TBL] [Abstract][Full Text] [Related]
40. The biology of malignant gliomas--a comprehensive survey.
McComb RD; Bigner DD
Clin Neuropathol; 1984; 3(3):93-106. PubMed ID: 6205806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
